ETF Objective

The Fund seeks to track the investment results of an index composed of large- and mid-capitalization emerging market equities. The Fund invests, under normal circumstances, at least 90% of its assets in the securities of its Underlying Index and in depositary receipts representing securities in its Underlying Index.

Stock Chart

as of 4:10 PM ET 10/18/2021


  • 1 Week
  • +2.15%
  • 1 Month
  • +0.86%
  • 3 Months
  • -3.32%
  • 1 Yr Return
  • +13.72%
  • 5 Yr Return
  • +38.20%

Sector Breakdown

Technology 25.46%
Financials 20.63%
Consumer Services 11.71%
Consumer Goods 9.94%
Industrials 8.03%
Basic Materials 7.77%
Oil & Gas 5.36%
Health Care 4.61%
Telecommunications 2.55%
Utilities 1.89%

Geographic Exposure

China 32.15%
Taiwan 14.69%
Korea 13.06%
India 11.65%
Brazil 5.05%
South Africa 3.16%
Saudi Arabia 3.16%
Russian Federation 2.99%
Hong Kong 2.26%
Mexico 1.98%
Thailand 1.69%
Malaysia 1.35%
Indonesia 1.23%
United Arab Emirates 0.77%
Qatar 0.70%
Poland 0.70%
Philippines 0.64%
Kuwait 0.57%
Chile 0.46%
Turkey 0.28%
Netherlands 0.28%
Luxembourg 0.28%
Cyprus 0.27%
Hungary 0.26%
Greece 0.18%
Colombia 0.16%
United States 0.14%
Czech Republic 0.12%
Peru 0.11%
Egypt 0.08%
Singapore 0.06%
Isle of Man 0.04%
Cayman Islands 0.03%
Unidentified 0.03%
Australia 0.02%
Pakistan 0.02%
Argentina 0.01%

Top 10 Holdings

Symbol Company Name % Of Assets
INFY Infosys Ltd ORD 0.97%
VALE3 Vale SA ORD 0.93%
JD JD.Com Inc DR 0.83%

ETF Overview

Sponsor BlackRock
iNav Ticker XPLH
Inception Date 04/07/2003
Name iShares:MSCI Em Mkts
CUSIP 464287234
Prospectus Date 12/30/2020

ETF Characteristics

Market Capitalization 144.27 B
Total Net Assets 29.75 K
Management Fee 0.70%
Administration Fee 0.00%
Asset Class Equity
Sub Asset Class Emerging Markets Funds
Number Of Holdings 1,291
Expense Ratio 0.70
Dividend 0.24
Dividend Frequency Semiannual


Recent Articles from TheStreet

After Red-hot IPO, Chinese Biotech Firm Kintor Eyes Blockbuster Drugs For Prostate Cancer, Sex Hormone-related Hair Loss

Atea Pharma Stock Plunges After COVID Treatment Trial Disappoints; Merck Jumps

Atea Pharmaceuticals could shed more than $2 billion in value Tuesday after the drugmaker said a mid-stage trial of its developing COVID treatment failed to meet expectations.

What to know about Cloudflare's Upcoming IPO

Investing in the Cloud: Consider Cloudflare and Digital Ocean

Cloud-software growth stocks have been a bright spot in an uncertain market. Investors might look closely at Cloudflare and Digital Ocean.

Philip Morris International Lead

Philip Morris Ekes Out Third-Quarter Earnings Beat

Philip Morris posts a third-quarter earnings beat as sales of its smokeless non-tobacco products continue strong, though cautions on supply chain impact.

The Travelers Companies Lead

Travelers Posts Third Quarter Earnings Beat on Record Net Written Premiums

Travelers Companies posts third-quarter earnings that exceed analysts’ forecasts as a drop in what it calls ‘catastrophic losses’ offsets record net written premiums.

Lufax is set to make the biggest splash on the NYSE by a Chinese company since e-commerce giant Alibaba's IPO in 2014. Photo: Reuters

Stock Market Today: Dow Gains On Earnings Strength; Housing Starts Disappoint

Solid third quarters continue to power stocks higher Tuesday, even as growth and inflation signals remain stubbornly persistent as oil prices top $85 a barrel in overnight trading.

Procter & Gamble Is Under Siege From an Activist Investor

Procter & Gamble Stock Slips After Q1 Earnings Beat; 2022 Forecast Unchanged

Procter & Gamble held its 2022 forecasts in place, seeing sales growth of between 2% and 4%, following stronger-than-expected first quarter earnings.

No More Tears for Johnson & Johnson?

Johnson & Johnson Stock Gains as Vaccine Sales Boost Q3 Earnings, 2021 Forecasts

Johnson & Johnson said it sees 2021 vaccine sales of $2.5 billion, with overall revenues rising to between $94.1 billion to $94.6 billion, following its Q3 earnings beat.

Stock Market Lead

Stocks Gain, SEC GameStop Report, Rent The Runway IPO - 5 Things You Must Know

Stocks edge higher ahead of earnings; SEC says GameStop surge powered by believers; FDA set to approve "mix & match' COVID boosters; DraftKings faces Entain bid deadline and Rent the Runway seeks $1.3 billion valuation in Nasdaq IPO.